Cargando…
Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real‐world studies
AIMS: Optimal diabetes care requires clear understanding of the incidence of hypoglycaemia in real‐world clinical practice. Current data on hypoglycaemia are generally limited to those reported from randomised controlled clinical trials. The Hypoglycaemia Assessment Tool (HAT) study, a non‐intervent...
Autores principales: | Pedersen‐Bjergaard, Ulrik, Alsifri, Saud, Aronson, Ronnie, Berković, Maja Cigrovski, Galstyan, Gagik, Gydesen, Helge, Lekdorf, Jesper Barner, Ludvik, Bernhard, Moberg, Erik, Ramachandran, Ambady, Khunti, Kamlesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590793/ https://www.ncbi.nlm.nih.gov/pubmed/30456887 http://dx.doi.org/10.1111/dom.13588 |
Ejemplares similares
-
Regional variations in definitions and rates of hypoglycaemia: findings from the global HAT observational study of 27 585 people with Type 1 and insulin‐treated Type 2 diabetes mellitus
por: Khunti, K., et al.
Publicado: (2018) -
Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study
por: Khunti, K., et al.
Publicado: (2016) -
Hypoglycaemia among Insulin-Treated Patients with Diabetes: Southeast Asia Cohort of IO HAT Study
por: Pathan, Faruque, et al.
Publicado: (2018) -
DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality
por: Pieber, Thomas R., et al.
Publicado: (2017) -
Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)
por: Zinman, Bernard, et al.
Publicado: (2017)